Test Price
3,000 AED✅ Home Collection Available
Deoxypyridinoline (DPD) Crosslinks Urine Test – UAE Bone Resorption Marker
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189:2022 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Home Collection & Temperature‑Controlled Cold‑Chain Logistics (available daily 8 AM–11 PM). Direct DHA‑licensed courier for urine specimen transport.
- Clinical Guidance: Complimentary telephonic post‑test interpretation session with a DHA‑licensed physician.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731 before sample collection.
- Regulatory Compliance: Fully aligned with Federal Decree‑Law No. 45 of 2021 (PDPL) and Federal Law No. 2 of 2019 for health data protection.
Test Overview & Methodology
The DPD Crosslinks Urine Test quantitatively measures deoxypyridinoline, a specific collagen crosslink released exclusively during bone resorption. As a gold‑standard biochemical marker of bone turnover, this assay supports the diagnosis of osteoporosis, monitoring of anti‑resorptive therapy efficacy, and assessment of metabolic bone disorders. The test is performed using a validated Quantitative Enzyme Immunoassay (ELISA) on a random urine specimen, normalized to creatinine to correct for dilutional variability.
| Feature | DPD Crosslinks Urine Test | Closest Alternative (Serum CTX‑1) |
|---|---|---|
| Precision / Method | Quantitative ELISA – direct DPD measurement; bone‑specific collagen marker unaffected by food intake or circadian variation | Immunoassay for C‑terminal telopeptide – influenced by prandial status and diurnal rhythm |
| Speed of Results | Sample by 7th of month; report within 2–3 weeks (batch processed for cost efficiency and analytical precision) | Typically 1–3 days but requires strict fasting and morning venipuncture |
| Clinical Utility | Reflects exclusively bone‑type collagen degradation; negligible dietary interference – ideal for longitudinal monitoring of osteoporosis treatment | Excellent for acute changes but less bone‑specific in patients with renal impairment or active inflammation |
Physician Insight & Safety Protocols
“As a General Practitioner focused on preventive medicine and bone health, I regularly use the DPD urine test to gain a non‑invasive window into skeletal turnover. This marker must always be interpreted alongside your full clinical history, DXA results, and serum biochemistry – no single value defines your bone status. Our DHA‑licensed laboratory operates under the highest quality standards, giving you a result you can trust for informed clinical decisions.”
— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132
Advisory – Medication Safety
⚠️ Do Not Discontinue Prescribed Therapy Without Medical Guidance
Continue all prescribed bisphosphonates, denosumab, calcium, or vitamin D supplements unless your treating physician advises otherwise. This test evaluates bone turnover and does not independently diagnose fracture risk or determine osteoporosis severity. Never alter therapy solely based on a laboratory result.
Exclusion Criteria & Emergency Red Flags
Who Should Not Take This Test
- Recent fracture or orthopaedic surgery (within 6 months) – may falsely elevate DPD.
- Severe renal impairment (eGFR <30 mL/min) – urinary marker is unreliable in this setting.
- Paediatric patients under 18 years – alternative bone turnover markers are recommended.
Symptoms Requiring Urgent Medical Attention
- Sudden, unexplained severe bone pain.
- Suspected pathological fracture (pain with minimal or no trauma).
- Acute spinal compression symptoms (numbness, weakness, or loss of bladder/bowel control).
Patient FAQ & Clinical Guidance
1. What is the DPD urine test and why is it ordered?
Key answer in 15 words: The DPD urine test measures a bone‑specific collagen breakdown product to evaluate bone resorption and osteoporosis progression.
Rheumatologists, endocrinologists, and primary care physicians order this test to monitor the effectiveness of antiresorptive medications (bisphosphonates, denosumab) and to identify high‑turnover bone loss. A random urine specimen (minimum 10 mL) is collected in a sterile container and must be accompanied by a signed DHA‑compliant Test Send‑Out Consent Form (Form 35).
2. How should I prepare for the DPD crosslinks urine test?
Key answer in 15 words: Provide a random urine specimen in a sterile container and avoid calcium supplements or high‑dose biotin 24 hours prior.
Collect a 20 mL aliquot (minimum 10 mL) of urine in a sterile screw‑capped container. Refrigerate or freeze immediately after collection and ship with cold packs. Our team will guide you through every step during home collection or at the facility. Complete the mandatory Form 35 completely to ensure regulatory compliance.
3. What do abnormal DPD results mean for my bone health?
Key answer in 15 words: Elevated urinary DPD signals accelerated bone resorption, often linked to osteoporosis, hyperparathyroidism, or bone metastases.
Values are interpreted as a creatinine‑normalised ratio to account for urine concentration. Persistently high levels while on treatment may indicate an inadequate therapeutic response, prompting therapy adjustment. A normal result does not exclude localised bone loss – always correlate with DXA scan and clinical findings.
4. Is the DPD test covered by health insurance in the UAE?
Key answer in 15 words: Coverage varies by insurer; verify with your provider or contact our billing team via WhatsApp for pre‑approval guidance.
Many comprehensive health insurance plans cover the DPD Crosslinks Urine Test when ordered for osteoporosis monitoring or metabolic bone disease. We recommend sending a copy of your insurance card to +971 54 548 8731 before your appointment to confirm direct billing eligibility and any applicable copayments.
UAE Regulatory & Data Privacy Adherence
Your Data, Your Rights – Fully Protected
DNA Labs UAE operates under the strictest regulatory framework for patient data and laboratory practice. All personal health information is processed in full compliance with:
- Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing collection, storage, and sharing of your personal data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensuring secure digital transmission of all health records.
- Federal Decree‑Law No. 4 of 2016 on Medical Liability – establishing your rights to informed consent and safe clinical practice.
Your test results are encrypted, stored in UAE‑based servers, and never shared with third parties without your explicit written consent. You have the right to access, correct, or request deletion of your data at any time by contacting our Data Protection Officer.
Clinical & Logistical Metadata
| Test Name | Deoxypyridinoline (DPD) Crosslinks, Urine |
| Price (AED) | 3,000 AED |
| Turnaround Time | 2–3 Weeks |
| Sample Type / Matrix | Urine (random specimen, 10–20 mL) |
| Methodology Used | Quantitative Enzyme Immunoassay (ELISA) |
| ICD-10-CM Code | M81.0, Z13.820 |
| LOINC Code | 14678-2 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians